Morris Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Morris Capital Advisors, LLC

$106 Million
Q3 2022

A detailed history of Morris Capital Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Morris Capital Advisors, LLC holds 4,347 shares of REGN stock, worth $4.57 Million. This represents 2.82% of its overall portfolio holdings.

Number of Shares

4,347

Previous 4,403 1.27%

Holding current value

$4.57 Million

Previous $2.6 Million 15.06%

% of portfolio

2.82%

Previous 2.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$573.97 - $724.32 $32,142 - $40,561	-56 Reduced 1.27%	4,347 $3 Million
Q2 2022 Jul 15, 2022	BUY	$548.35 - $738.84 $42,771 - $57,629	78 Added 1.8%	4,403 $2.6 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $55,941 - $65,652	-94 Reduced 2.13%	4,325 $3.02 Million
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $29,891 - $36,903	-55 Reduced 1.23%	4,419 $2.79 Million
Q3 2021 Oct 22, 2021	SELL	$574.03 - $680.96 $71,179 - $84,439	-124 Reduced 2.7%	4,474 $2.71 Million

Q2 2021 Jul 15, 2021	BUY	$472.8 - $558.54 $52,008 - $61,439	110 Added 2.45%	4,598 $2.57 Million
Q1 2021 Apr 16, 2021	SELL	$446.73 - $548.2 $51,820 - $63,591	-116 Reduced 2.52%	4,488 $2.12 Million
Q4 2020 Jan 19, 2021	SELL	$478.3 - $607.98 $137,272 - $174,490	-287 Reduced 5.87%	4,604 $2.22 Million
Q3 2020 Oct 19, 2020	SELL	$544.75 - $658.21 $136,732 - $165,210	-251 Reduced 4.88%	4,891 $2.74 Million
Q2 2020 Jul 23, 2020	SELL	$493.32 - $643.92 $2.62 Million - $3.42 Million	-5,309 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $1.78 Million - $2.62 Million	5,309 New	5,309 $2.59 Million

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morris Capital Advisors, LLC with notifications on news.

Account

Morris Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History